Profile data is unavailable for this security.
About the company
Rite Aid Corporation is a healthcare company that operates retail drugstore chain. The Company is principally engaged in providing its service to customers and communities through various programs. Its business segments include Retail Pharmacy segment and Pharmacy Services segment. Retail Pharmacy segment sells brand and generic prescription drugs and various other pharmacy services, as well as front-end products, including health and beauty aids, personal care products and seasonal merchandise. Its Retail Pharmacy segment operates approximately 2,400 retail pharmacy locations across 17 states. Pharmacy Services segment provides a range of pharmacy benefit services through Elixir. Elixir also offers integrated mail-order and specialty pharmacy services through Elixir Pharmacy. The Pharmacy Services segment provides both transparent and traditional pharmacy benefit management (PBM) options through its Elixir PBM. The Company's clients include employers, insurance companies and unions.
- Revenue in USD (TTM)24.42bn
- Net income in USD-167.91m
- Incorporated1968
- Employees50.00k
- LocationRite Aid Corp30 Hunter LnCAMP HILL 17011-2400United StatesUSA
- Phone+1 (717) 761-2633
- Fax+1 (302) 655-5049
- Websitehttps://www.riteaid.com/
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Homology Medicines Inc | 34.15m | -91.97m | 192.60m | 205.00 | -- | 0.9699 | -- | 5.64 | -1.72 | -1.72 | 0.6443 | 3.47 | 0.1487 | -- | -- | 166,580.50 | -40.06 | -- | -43.46 | -- | -- | -- | -269.33 | -- | -- | -- | 0.00 | -- | 62.18 | -- | -23.84 | -- | -- | -- |
| Marimed Inc | 110.78m | 17.85m | 251.52m | 181.00 | 16.53 | 6.79 | 12.08 | 2.27 | 0.0457 | 0.0457 | 0.2729 | 0.225 | 1.16 | 5.44 | 17.33 | 612,030.90 | 19.12 | -41.47 | 25.26 | -64.62 | 56.32 | 53.96 | 16.46 | -79.22 | 1.73 | 7.20 | 0.2097 | -- | 11.60 | 109.20 | 102.64 | -- | 10.15 | -- |
| Tabula Rasa HealthCare Inc | 322.63m | -88.31m | 359.80m | 1.61k | -- | 5.21 | -- | 1.12 | -3.84 | -3.84 | 13.99 | 2.69 | 0.6727 | 48.97 | 8.28 | 199,892.80 | -18.41 | -11.73 | -20.54 | -14.05 | 29.25 | 32.71 | -27.37 | -15.15 | 1.27 | -4.93 | 0.839 | -- | 4.39 | 33.52 | -149.62 | -- | 79.58 | -- |
| Petmed Express Inc | 284.27m | 25.20m | 502.84m | 219.00 | 19.30 | 3.55 | 18.09 | 1.77 | 1.24 | 1.24 | 14.03 | 6.76 | 1.79 | 9.87 | 139.83 | 1,298,050.00 | 15.83 | 21.95 | 17.94 | 25.86 | 28.53 | 31.69 | 8.86 | 10.92 | 6.99 | -- | 0.00 | 65.08 | 8.83 | 5.67 | 18.38 | 8.27 | -34.47 | 9.24 |
| Rite Aid Corporation | 24.42bn | -167.91m | 589.06m | 50.00k | -- | 1.25 | 4.45 | 0.0241 | -3.11 | -3.11 | 452.59 | 8.47 | 2.58 | 9.90 | 13.51 | 488,394.40 | -1.77 | -2.62 | -2.52 | -3.76 | 20.49 | 21.39 | -0.6876 | -1.12 | 0.7141 | 0.7315 | 0.871 | -- | 9.64 | 2.97 | 78.67 | -- | -14.10 | -- |
| Prestige Consumer Healthcare Inc | 1.02bn | 179.47m | 2.90bn | 505.00 | 16.33 | 1.99 | 13.82 | 2.84 | 3.55 | 3.55 | 20.23 | 29.18 | 0.2875 | 3.87 | 7.60 | 2,023,673.00 | 5.05 | 2.31 | 5.26 | 2.40 | 57.99 | 57.13 | 17.56 | 8.57 | 1.32 | 4.46 | 0.5237 | 0.00 | -2.04 | 3.19 | 15.74 | 10.51 | 44.20 | -- |
| Holder | Shares | % Held |
|---|---|---|
| The Vanguard Group, Inc.as of 30 Sep 2021 | 5.08m | 9.10% |
| BlackRock Fund Advisorsas of 30 Sep 2021 | 3.91m | 7.01% |
| Invesco Advisers, Inc.as of 30 Sep 2021 | 2.50m | 4.49% |
| SSgA Funds Management, Inc.as of 30 Sep 2021 | 1.68m | 3.02% |
| Dimensional Fund Advisors LPas of 30 Sep 2021 | 1.08m | 1.93% |
| Great Lakes Advisors LLCas of 30 Sep 2021 | 983.44k | 1.76% |
| Two Sigma Advisers LPas of 30 Sep 2021 | 945.45k | 1.70% |
| Geode Capital Management LLCas of 30 Sep 2021 | 915.93k | 1.64% |
| Two Sigma Investments LPas of 30 Sep 2021 | 878.19k | 1.58% |
| Northern Trust Investments, Inc.(Investment Management)as of 30 Sep 2021 | 724.80k | 1.30% |
